Non–Small Cell Lung Cancer as a Second Primary Among Patients With Previous Malignancy: Who Is at Risk?

Clinical Lung Cancer

Volumn 18, Issue 5, 2017, Pages 543-550.e3

  Wu, Geena X ^a   Nelson, Rebecca A ^a   Kim, Jae Y ^a   Raz, Dan J ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

NSCLC; Radiation; Screening criteria; Smoking; Survivor

Indexed keywords

ADULT; AGED; BLADDER CANCER; BREAST CANCER; CANCER INCIDENCE; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RISK; CANCER SCREENING; CANCER SURVIVOR; COLORECTAL CANCER; CONFERENCE PAPER; FEMALE; FOLLOW UP; HEAD AND NECK CANCER; HUMAN; KIDNEY CANCER; LUNG ADENOCARCINOMA; MAJOR CLINICAL STUDY; MALE; MELANOMA; NON SMALL CELL LUNG CANCER; PANCREAS CANCER; PATIENT RISK; PROSTATE CANCER; SECOND CANCER; SMOKING; STANDARDIZED INCIDENCE RATIO; THYROID CANCER; UTERUS CANCER; ADENOCARCINOMA; BLADDER TUMOR; BREAST TUMOR; CANCER REGISTRY; COLORECTAL TUMOR; ETHNOLOGY; HEAD AND NECK TUMOR; HEMATOLOGIC DISEASE; INCIDENCE; KIDNEY TUMOR; LUNG TUMOR; MIDDLE AGED; PANCREAS TUMOR; PROSTATE TUMOR; RISK FACTOR; SEX FACTOR; THYROID TUMOR; UNITED STATES;

ADENOCARCINOMA; AGED; BREAST NEOPLASMS; CARCINOMA, NON-SMALL-CELL LUNG; COLORECTAL NEOPLASMS; FEMALE; HEAD AND NECK NEOPLASMS; HEMATOLOGIC NEOPLASMS; HUMANS; INCIDENCE; KIDNEY NEOPLASMS; LUNG NEOPLASMS; MALE; MELANOMA; MIDDLE AGED; NEOPLASMS, SECOND PRIMARY; PANCREATIC NEOPLASMS; PROSTATIC NEOPLASMS; RISK FACTORS; SEER PROGRAM; SEX FACTORS; SMOKING; THYROID NEOPLASMS; UNITED STATES; URINARY BLADDER NEOPLASMS; UTERINE NEOPLASMS;

EID: 85017391813     PISSN: 15257304     EISSN: 19380690     Source Type: Journal    
DOI: 10.1016/j.cllc.2017.02.007     Document Type: Conference Paper

References (29)

1. National Lung Screening Trial Research Team, Aberle, D.R., Adams, A.M., et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 365 (2011), 395–409.
2. Moyer, V.A., US Preventive Services Task Force. Screening for lung cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 160 (2014), 330–338.
3. Mery, C.M., Pappas, A.N., Bueno, R., et al. Relationship between a history of antecedent cancer and the probability of malignancy for a solitary pulmonary nodule. Chest 125 (2004), 2175–2181.
4. Wood, D.E., Eapen, G.A., Ettinger, D.S., et al. Lung cancer screening. J Natl Compr Canc Netw 10 (2012), 240–265.
5. Jaklitsch, M.T., Jacobson, F.L., Austin, J.H., et al. The American Association for Thoracic Surgery guidelines for lung cancer screening using low-dose computed tomography scans for lung cancer survivors and other high-risk groups. J Thorac Cardiovasc Surg 144 (2012), 33–38.
6. Johnson, B.E., Second lung cancers in patients after treatment for an initial lung cancer. J Natl Cancer Inst 90 (1998), 1335–1345.
7. Boyle, J.M., Tandberg, D.J., Chino, J.P., D'Amico, T.A., Ready, N.E., Kelsey, C.R., Smoking history predicts for increased risk of second primary lung cancer: a comprehensive analysis. Cancer 121 (2015), 598–604.
8. Milano, M.T., Peterson, C.R. III, Zhang, H., Singh, D.P., Chen, Y., Second primary lung cancer after head and neck squamous cell cancer: population-based study of risk factors. Head Neck 34 (2012), 1782–1788.
9. Ibrahim, E.M., Kazkaz, G.A., Abouelkhair, K.M., et al. Increased risk of second lung cancer in Hodgkin's lymphoma survivors: a meta-analysis. Lung 191 (2013), 117–134.
10. Das, P., Ng, A.K., Earle, C.C., Mauch, P.M., Kuntz, K.M., Computed tomography screening for lung cancer in Hodgkin's lymphoma survivors: decision analysis and cost-effectiveness analysis. Ann Oncol 17 (2006), 785–793.
11. Miyazaki, K., Satoh, H., Kagohashi, K., et al. Lung cancer patients with previous or simultaneous urologic cancers. Med Oncol 25 (2008), 443–446.
12. Rusthoven, K.E., Flaig, T.W., Raben, D., Kavanagh, B.D., High incidence of lung cancer after non-muscle-invasive transitional cell carcinoma of the bladder: implications for screening trials. Clin Lung Cancer 9 (2008), 106–111.
13. Chaturvedi, A.K., Kleinerman, R.A., Hildesheim, A., et al. Second cancers after squamous cell carcinoma and adenocarcinoma of the cervix. J Clin Oncol 27 (2009), 967–973.
14. Chaturvedi, A.K., Engels, E.A., Gilbert, E.S., et al. Second cancers among 104,760 survivors of cervical cancer: evaluation of long-term risk. J Natl Cancer Inst 99 (2007), 1634–1643.
15. Deutsch, M., Land, S.R., Begovic, M., Wieand, H.S., Wolmark, N., Fisher, B., The incidence of lung carcinoma after surgery for breast carcinoma with and without postoperative radiotherapy: results of National Surgical Adjuvant Breast and Bowel Project (NSABP) clinical trials B-04 and B-06. Cancer 98 (2003), 1362–1368.
16. Grantzau, T., Thomsen, M.S., Vaeth, M., Overgaard, J., Risk of second primary lung cancer in women after radiotherapy for breast cancer. Radiother Oncol 111 (2014), 366–373.
17. Kaufman, E.L., Jacobson, J.S., Hershman, D.L., Desai, M., Neugut, A.I., Effect of breast cancer radiotherapy and cigarette smoking on risk of second primary lung cancer. J Clin Oncol 26 (2008), 392–398.
18. Lorigan, P., Califano, R., Faivre-Finn, C., Howell, A., Thatcher, N., Lung cancer after treatment for breast cancer. Lancet Oncol 11 (2010), 1184–1192.
19. Prochazka, M., Granath, F., Ekbom, A., Shields, P.G., Hall, P., Lung cancer risks in women with previous breast cancer. Eur J Cancer 38 (2002), 1520–1525.
20. Neugut, A.I., Murray, T., Santos, J., et al. Increased risk of lung cancer after breast cancer radiation therapy in cigarette smokers. Cancer 73 (1994), 1615–1620.
21. Zablotska, L.B., Neugut, A.I., Lung carcinoma after radiation therapy in women treated with lumpectomy or mastectomy for primary breast carcinoma. Cancer 97 (2003), 1404–1411.
22. Travis, L.B., The epidemiology of second primary cancers. Cancer Epidemiol Biomarkers Prev 15 (2006), 2020–2026.
23. Surveillance, Epidemiology, and End Results (SEER) Program. SEER*Stat database: incidence—SEER 18 Regs Research Data + Hurricane Katrina Impacted Louisiana Cases, Nov 2013 Sub (1973-2011 varying)—linked to county attributes—total U.S., 1969-2012 counties. National Cancer Institute, Division of Cancer Control and Population Science, Surveillance Research Program, Surveillance Systems Branch, released April 2014 (updated May 7, 2014), based on the November 2013 submission.
24. Davis, E.J., Beebe-Dimmer, J.L., Yee, C.L., Cooney, K.A., Risk of second primary tumors in men diagnosed with prostate cancer: a population-based cohort study. Cancer 120 (2014), 2735–2741.
25. Milano, M.T., Strawderman, R.L., Venigalla, S., Ng, K., Travis, L.B., Non-small-cell lung cancer after breast cancer: a population-based study of clinicopathologic characteristics and survival outcomes in 3529 women. J Thorac Oncol 9 (2014), 1081–1090.
26. Sahai, H., Khurshid, A., Statistics in epidemiology: methods, techniques, and applications. 1996, CRC Press, Boca Raton.
27. Pages, P.B., Mordant, P., Cazes, A., et al. Prognosis of lung cancer resection in patients with previous extra-respiratory solid malignancies. Eur J Cardiothorac Surg 44 (2013), 534–538.
28. Baik, C.S., Strauss, G.M., Speizer, F.E., Feskanich, D., Reproductive factors, hormone use, and risk for lung cancer in postmenopausal women, the Nurses' Health Study. Cancer Epidemiol Biomarkers Prev 19 (2010), 2525–2533.
29. Pesatori, A.C., Carugno, M., Consonni, D., et al. Hormone use and risk for lung cancer: a pooled analysis from the International Lung Cancer Consortium (ILCCO). Br J Cancer 109 (2013), 1954–1964.